You are here

Co-Administration Of Methotrexate And CP-690,550

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Daytona Beach, Florida, 32114 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Rheumatoid Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Adults diagnosed with moderate to severe RA (Rheumatoid Arthritis)

- Diagnosis of RA based on the American College of Rheumatology 1987 revised criteria.

- Treatment with an oral stable weekly dose of Methotrexate (MTX) (15-25 mg/week,
administered as a single dose [SD]) for a minimum of 4 doses (4 weeks)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Blood dyscrasias including confirmed: Hemoglobin blood cell count

- Evidence or history of clinically significant infections within the past 6 months (eg,
those requiring hospitalization, requiring parenteral antimicrobial therapy, or those
with recurrent oral or genital herpes, recurrent herpes zoster, or any infection
otherwise judged by the investigator to have the potential for exacerbation by
participation in the trial.

- Total bilirubin, AST (aspartate aminotransferase) or ALT (alanine aminotransferase)
more than 1.2 times the upper limit of normal at the Screening visit, or a history of
clinically significant elevated liver function tests (LFTs) while on current MTX dose
or chronic liver disease, recent or active hepatitis.

NCT01745055
Pfizer
Completed
Co-Administration Of Methotrexate And CP-690,550

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Rheumatoid Arthritis, Psoriasis Arthritis
NCT01623752
All Genders
Rheumatoid Arthritis
NCT03703817
All Genders
19+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now